| Primary |
| Parkinson's Disease |
69.0% |
| Restless Legs Syndrome |
10.5% |
| Drug Use For Unknown Indication |
7.7% |
| Product Used For Unknown Indication |
6.9% |
| Depression |
2.1% |
| Routine Health Maintenance |
0.5% |
| Constipation |
0.3% |
| Dyskinesia |
0.3% |
| Motor Dysfunction |
0.3% |
| Musculoskeletal Disorder |
0.3% |
| Ovarian Cancer |
0.3% |
| Pain |
0.3% |
| Anxiety |
0.2% |
| Blood Cholesterol Increased |
0.2% |
| Cardiovascular Event Prophylaxis |
0.2% |
| Coagulopathy |
0.2% |
| Dental Disorder Prophylaxis |
0.2% |
| Dystonia |
0.2% |
| Fluid Retention |
0.2% |
| Gait Disturbance |
0.2% |
|
| Somnolence |
12.2% |
| Tremor |
11.7% |
| Hallucination |
9.0% |
| Nausea |
9.0% |
| Drug Ineffective |
7.2% |
| Medication Residue |
5.0% |
| Withdrawal Syndrome |
5.0% |
| Oedema Peripheral |
4.5% |
| Parkinson's Disease |
4.5% |
| Product Quality Issue |
4.1% |
| Restless Legs Syndrome |
3.6% |
| Insomnia |
3.2% |
| Vomiting |
3.2% |
| Balance Disorder |
2.7% |
| Death |
2.7% |
| Malaise |
2.7% |
| Overdose |
2.7% |
| Therapeutic Response Decreased |
2.7% |
| Pain In Extremity |
2.3% |
| Psychotic Disorder |
2.3% |
|
| Secondary |
| Parkinson's Disease |
48.4% |
| Restless Legs Syndrome |
35.5% |
| Product Used For Unknown Indication |
7.8% |
| Drug Use For Unknown Indication |
2.3% |
| Depression |
1.4% |
| Muscle Spasms |
0.9% |
| Rhinitis Allergic |
0.9% |
| Anxiety |
0.5% |
| Asthma |
0.5% |
| Feeling Jittery |
0.5% |
| Migraine |
0.5% |
| Pain |
0.5% |
| Sedation |
0.5% |
|
| Somnolence |
19.6% |
| Transient Ischaemic Attack |
8.9% |
| Tremor |
8.9% |
| Drug Ineffective |
7.1% |
| Nausea |
5.4% |
| Restless Legs Syndrome |
5.4% |
| Somnambulism |
5.4% |
| Swelling |
5.4% |
| Hypersexuality |
3.6% |
| Libido Increased |
3.6% |
| Obsessive-compulsive Personality Disorder |
3.6% |
| Oedema Peripheral |
3.6% |
| Product Quality Issue |
3.6% |
| Sedation |
3.6% |
| Speech Disorder |
3.6% |
| Adverse Event |
1.8% |
| Alcohol Abuse |
1.8% |
| Atrial Fibrillation |
1.8% |
| Blood Bilirubin Increased |
1.8% |
| Blood Urine Present |
1.8% |
|
| Concomitant |
| Parkinson's Disease |
28.3% |
| Product Used For Unknown Indication |
16.8% |
| Depression |
5.4% |
| Diabetes Mellitus |
5.4% |
| Sleep Disorder |
5.4% |
| Constipation |
4.3% |
| Restless Legs Syndrome |
4.3% |
| Multiple Sclerosis |
3.3% |
| Pain |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Arthralgia |
2.2% |
| Cough |
2.2% |
| Hypertension |
2.2% |
| Menopause |
2.2% |
| Neuropathy Peripheral |
2.2% |
| Blood Pressure |
1.6% |
| Cardiac Disorder |
1.6% |
| Prophylaxis |
1.6% |
| Urinary Incontinence |
1.6% |
|
| Nausea |
12.1% |
| Posture Abnormal |
12.1% |
| Urinary Tract Infection |
9.1% |
| Hypokinesia |
6.1% |
| Intraocular Melanoma |
6.1% |
| Rectal Cancer |
6.1% |
| Urinary Retention |
6.1% |
| Urticaria |
6.1% |
| Adverse Event |
3.0% |
| Back Pain |
3.0% |
| Cerebrovascular Accident |
3.0% |
| Death |
3.0% |
| Delirium |
3.0% |
| Drug Dose Omission |
3.0% |
| Drug Ineffective |
3.0% |
| Dysphagia |
3.0% |
| Freezing Phenomenon |
3.0% |
| Hallucination |
3.0% |
| Injection Site Pain |
3.0% |
| Ligament Rupture |
3.0% |
|
| Interacting |
| Parkinson's Disease |
100.0% |
|
|
